LOU/c/jall rat as a model of resilience in the context of streptozotocin-induced cognitive impairment
Understanding the role of these proteins in AD could improve our understanding of the brain mechanisms underlying CR and guide the development of more targeted therapeutic strategies.
Authors
- Benoı̂t Bernay (ORCID: https://orcid.org/0000-0002-3624-1514)
- Sophie Corvaisier (ORCID: https://orcid.org/0000-0002-4242-6179)
- Marianne Léger (ORCID: https://orcid.org/0000-0002-7811-8522)
- Thomas Fréret (ORCID: https://orcid.org/0000-0002-4446-4451)
- Lucas Gephine
Institutions
- Inserm (FR)
- COMETE - Mobilités : Vieillissement, pathologie, santé (FR)
- Normandie Université (FR)
- Centre Hospitalier Universitaire de Caen Normandie (FR)
- Cyceron (FR)
- Chimie Organique, Médicinale et Extractive et Toxicologie Expérimentale (FR)
- Université de Caen Normandie (FR)
Publication Details
- Journal
- Frontiers in Aging Neuroscience
- Published
- 2025-10-16
- DOI
- https://doi.org/10.3389/fnagi.2025.1666397
- Primary Topic
- Tryptophan and brain disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- BrightFocus Foundation
- Fondation Vaincre Alzheimer